\-\ Texto\\:\\ \ \(0\)\
\-\ axillary\\ lesions\\:\\ multiple\\ 2\\-3mm\\ hyperpigmented\\ macules\\ in\\ the\\ bilateral\\ axilla\\.\ \(0\)\
\-\ upper\\ extremities\\ and\\ back\\ with\\ large\\ hyperpigmented\\ macules\\ and\\ patches\\ in\\ various\\ size\\ consistent\\ with\\ caf\\?\\ au\\ lait\\ spots\\.\ \(0\)\
\-\ lower\\ extremities\\:\\ large\\ 18\\ x\\ 9cm\\ boggy\\ hyperpigmented\\ plaque\\ on\\ the\\ left\\ lateral\\ thigh\\.\\ it\\ has\\ a\\ \\"bag\\ of\\ worms\\"\\ feel\\ and\\ is\\ moderately\\ tender\\ on\\ palpation\\.\ \(0\)\
\-\ the\\ patient\\ was\\ advised\\ to\\ follow\\ up\\ with\\ her\\ obgyn\\ for\\ routine\\ pregnancy\\ care\\.\\ there\\ is\\ no\\ specific\\ treatment\\ for\\ neurofibromatosis\\ type\\ 1\\,\\ but\\ routine\\ surveillance\\ for\\ complications\\ is\\ recommended\\.\\ the\\ patient\\ was\\ counseled\\ to\\ seek\\ follow\\ up\\ with\\ an\\ ophthalmologist\\ for\\ a\\ full\\ eye\\ exam\\ and\\ to\\ maintain\\ regular\\ follow\\ ups\\ with\\ her\\ primary\\ care\\ physician\\.\\ there\\ is\\ the\\ potential\\ for\\ large\\ plexiform\\ lesions\\ to\\ undergo\\ malignant\\ degeneration\\ which\\ could\\ present\\ as\\ rapid\\ change\\ in\\ size\\ and\\ increased\\ pain\\.\\ at\\ this\\ time\\,\\ the\\ punch\\ biopsy\\ showed\\ no\\ malignant\\ changes\\.\\ no\\ further\\ treatment\\ of\\ the\\ mass\\ was\\ warranted\\,\\ but\\ the\\ patient\\ was\\ encouraged\\ to\\ follow\\ up\\ later\\ after\\ delivery\\.\ \(0\)\
\-\ the\\ images\\ below\\ demonstrate\\ a\\ large\\ subcutaneous\\ mass\\ on\\ the\\ left\\ lower\\ extremity\\.\ \(0\)\
\-\ neurofibromatosis\\ type\\ 1\ \(7\)\
\-\ differential\\ includes\\ leguis\\ syndrome\\,\\ mccune\\-albright\\ syndrome\\,\\ and\\ watson\\ syndrome\ \(0\)\
\-\ this\\ is\\ a\\ 21\\ year\\ old\\ g2p1\\ at\\ 28\\ weeks\\ who\\ presents\\ for\\ evaluation\\ of\\ a\\ large\\ mass\\ on\\ her\\ left\\ lateral\\ thigh\\.\\ the\\ mass\\ has\\ been\\ present\\ since\\ childhood\\ and\\ has\\ been\\ stable\\ in\\ size\\ for\\ many\\ years\\.\\ during\\ her\\ current\\ pregnancy\\,\\ the\\ mass\\ began\\ to\\ grow\\ slightly\\ and\\ increased\\ in\\ pain\\.\\ the\\ patient\\ endorses\\ pain\\ with\\ minor\\ trauma\\ that\\ lasts\\ for\\ days\\.\\ the\\ patient\\ denies\\ any\\ weakness\\ or\\ altered\\ sensation\\ in\\ the\\ leg\\.\\ no\\ night\\ sweats\\,\\ fevers\\,\\ chills\\,\\ or\\ weight\\ loss\\ noted\\ by\\ the\\ patient\\.\ \(0\)\
\-\ this\\ is\\ a\\ 22\\ year\\ old\\ g2p1\\ at\\ 28\\ weeks\\,\\ with\\ a\\ pmh\\ of\\ neurofibromatosis\\ type\\ 1\\,\\ who\\ presented\\ for\\ evaluation\\ of\\ a\\ large\\ mass\\ on\\ her\\ left\\ lateral\\ thigh\\.\\ \\ a\\ punch\\ biopsy\\ was\\ performed\\ to\\ rule\\ out\\ malignant\\ degeneration\\ into\\ a\\ peripheral\\ nerve\\ sheath\\ tumor\\.\\ punch\\ biopsy\\ of\\ the\\ lesion\\ revealed\\ a\\ plexiform\\ neurofibroma\\ without\\ malignant\\ changes\\.\\ malignant\\ peripheral\\ nerve\\ sheath\\ tumors\\ can\\ occur\\ from\\ large\\ plexiform\\ lesions\\.\\ patient\\'s\\ with\\ neurofibromatosis\\ type\\ 1\\ have\\ a\\ 10\\%\\ lifetime\\ risk\\ of\\ developing\\ one\\ of\\ these\\ tumors\\.\\ routine\\ surveillance\\ of\\ large\\ neurofibromas\\ especially\\ plexiform\\ neurofibromas\\ is\\ recommended\\.\\ plexiform\\ neurofibromas\\ can\\ grow\\ to\\ be\\ very\\ large\\ and\\ locally\\ invasive\\ which\\ can\\ lead\\ to\\ cosmetic\\ and\\ functional\\ concerns\\.\\ complete\\ resection\\ of\\ the\\ lesion\\ is\\ difficult\\ but\\ can\\ be\\ undertaken\\ if\\ if\\ the\\ lesion\\ causes\\ the\\ patient\\ functional\\ problems\\ or\\ cosmetic\\ concerns\\.\\ \ \(0\)\
\-\ source\\:\\ kevin\\ p\\.\\ boyd\\,\\ bruce\\ r\\.\\ korf\\,\\ amy\\ theos\\,\\ neurofibromatosis\\ type\\ 1\\,\\ journal\\ of\\ the\\ american\\ academy\\ of\\ dermatology\\,\\ volume\\ 61\\,\\ issue\\ 1\\,\\ 2009\\,\\ pages\\ 1\\-14\\,\\ issn\\ 0190\\-9622\\,\\ http\\:\\/\\/dx\\.doi\\.org\\/10\\.1016\\/j\\.jaad\\.2008\\.12\\.051\\.\ \(0\)\
\-\ \\(http\\:\\/\\/www\\.sciencedirect\\.com\\/science\\/article\\/pii\\/s0190962209004058\\)\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ plexiform\\:\\ 0\\.06552766184782453\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.04674429566083562\ \(0\)\
\-\ hyperpigmented\\:\\ 0\\.04080955410838328\ \(0\)\
\-\ punch\\:\\ 0\\.038690693055281895\ \(0\)\
\-\ neurofibromas\\:\\ 0\\.03760759469809009\ \(0\)\
\-\ large\\:\\ 0\\.03330075621085092\ \(0\)\
\-\ malignant\\:\\ 0\\.030580897785933675\ \(0\)\
\-\ type\\:\\ 0\\.028521031963830795\ \(0\)\
\-\ g2p1\\:\\ 0\\.027816867147478982\ \(0\)\
\-\ thigh\\:\\ 0\\.027756734837079005\ \(0\)\
\-\ macules\\:\\ 0\\.026211064739129816\ \(0\)\
\-\ her\\:\\ 0\\.025439719390939957\ \(0\)\
\-\ cosmetic\\:\\ 0\\.024754728976257273\ \(0\)\
\-\ concerns\\:\\ 0\\.024754728976257273\ \(0\)\
\-\ 1\\:\\ 0\\.024158333084669786\ \(0\)\
\-\ grow\\:\\ 0\\.02200959162750501\ \(0\)\
\-\ follow\\:\\ 0\\.021506530470862845\ \(0\)\
\-\ surveillance\\:\\ 0\\.021065389554455517\ \(0\)\
\-\ routine\\:\\ 0\\.0203551288761386\ \(0\)\
\-\ sheath\\:\\ 0\\.018632255682349254\ \(0\)\
\-\ functional\\:\\ 0\\.018632255682349254\ \(0\)\
\-\ biopsy\\:\\ 0\\.01801005886120848\ \(0\)\
\-\ leguis\\:\\ 0\\.017456472126666334\ \(0\)\
\-\ kevin\\:\\ 0\\.017456472126666334\ \(0\)\
\-\ boyd\\:\\ 0\\.017456472126666334\ \(0\)\
\-\ korf\\:\\ 0\\.017456472126666334\ \(0\)\
\-\ amy\\:\\ 0\\.017456472126666334\ \(0\)\
\-\ theos\\:\\ 0\\.017456472126666334\ \(0\)\
\-\ 0190\\-9622\\:\\ 0\\.017456472126666334\ \(0\)\
\-\ \\/\\/dx\\.doi\\.org\\/10\\.1016\\/j\\.jaad\\.2008\\.12\\.051\\:\\ 0\\.017456472126666334\ \(0\)\
\-\ \\/\\/www\\.sciencedirect\\.com\\/science\\/article\\/pii\\/s0190962209004058\\:\\ 0\\.017456472126666334\ \(0\)\
\-\ degeneration\\:\\ 0\\.017180917265300164\ \(0\)\
\-\ size\\:\\ 0\\.017019064582448146\ \(0\)\
\-\ mccune\\-albright\\:\\ 0\\.016083903452290205\ \(0\)\
\-\ 1\\-14\\:\\ 0\\.016083903452290205\ \(0\)\
\-\ issn\\:\\ 0\\.016083903452290205\ \(0\)\
\-\ 28\\:\\ 0\\.01595258091558199\ \(0\)\
\-\ can\\:\\ 0\\.015352256257180749\ \(0\)\
\-\ au\\:\\ 0\\.01528100224811562\ \(0\)\
\-\ lait\\:\\ 0\\.01528100224811562\ \(0\)\
\-\ 9cm\\:\\ 0\\.01528100224811562\ \(0\)\
\-\ ups\\:\\ 0\\.01528100224811562\ \(0\)\
\-\ watson\\:\\ 0\\.01528100224811562\ \(0\)\
\-\ caf\\:\\ 0\\.014711334777914075\ \(0\)\
\-\ bruce\\:\\ 0\\.014711334777914075\ \(0\)\
\-\ pregnancy\\:\\ 0\\.014549920267183518\ \(0\)\
\-\ syndrome\\:\\ 0\\.01451825689149292\ \(0\)\
\-\ 2\\-3mm\\:\\ 0\\.014269466359470094\ \(0\)\
\-\ obgyn\\:\\ 0\\.014269466359470094\ \(0\)\
\-\ mass\\:\\ 0\\.014120328795416609\ \(0\)\
\-\ recommended\\:\\ 0\\.014029777684763373\ \(0\)\
\-\ boggy\\:\\ 0\\.013908433573739491\ \(0\)\
\-\ worms\\:\\ 0\\.013908433573739491\ \(0\)\
\-\ lasts\\:\\ 0\\.013908433573739491\ \(0\)\
\-\ academy\\:\\ 0\\.013908433573739491\ \(0\)\
\-\ up\\:\\ 0\\.013650577134975585\ \(0\)\
\-\ counseled\\:\\ 0\\.013603184702794426\ \(0\)\
\-\ lesions\\:\\ 0\\.013589468354518502\ \(0\)\
\-\ patient\\:\\ 0\\.013569773163031889\ \(0\)\
\-\ lifetime\\:\\ 0\\.013338766103537946\ \(0\)\
\-\ pages\\:\\ 0\\.013338766103537946\ \(0\)\
\-\ extremities\\:\\ 0\\.013274006411647082\ \(0\)\
\-\ for\\:\\ 0\\.01299400660947413\ \(0\)\
\-\ http\\:\\ 0\\.012815004348436736\ \(0\)\
\-\ tumors\\:\\ 0\\.012711747951170301\ \(0\)\
\-\ patches\\:\\ 0\\.012535864899363362\ \(0\)\
\-\ bag\\:\\ 0\\.012535864899363362\ \(0\)\
\-\ feel\\:\\ 0\\.012535864899363362\ \(0\)\
\-\ ophthalmologist\\:\\ 0\\.012535864899363362\ \(0\)\
\-\ endorses\\:\\ 0\\.012535864899363362\ \(0\)\
\-\ encouraged\\:\\ 0\\.012377364488128637\ \(0\)\
\-\ peripheral\\:\\ 0\\.012245280483224227\ \(0\)\
\-\ undertaken\\:\\ 0\\.012230616028418297\ \(0\)\
\-\ care\\:\\ 0\\.012206642166608921\ \(0\)\
\-\ nerve\\:\\ 0\\.012193846045494281\ \(0\)\
\-\ axilla\\:\\ 0\\.011846148673089668\ \(0\)\
\-\ spots\\:\\ 0\\.011846148673089668\ \(0\)\
\-\ issue\\:\\ 0\\.01173296369518878\ \(0\)\
\-\ locally\\:\\ 0\\.011625899890693184\ \(0\)\
\-\ seek\\:\\ 0\\.011524329010717836\ \(0\)\
\-\ \\,\\:\\ 0\\.011257250249233733\ \(0\)\
\-\ \\:\\:\\ 0\\.011190839762283812\ \(0\)\
\-\ p\\.\\:\\ 0\\.011163296224987232\ \(0\)\
\-\ lateral\\:\\ 0\\.010970305221531982\ \(0\)\
\-\ r\\.\\:\\ 0\\.010930062491014197\ \(0\)\
\-\ but\\:\\ 0\\.01082675228336755\ \(0\)\
\-\ 2009\\:\\ 0\\.010788559592039651\ \(0\)\
\-\ warranted\\:\\ 0\\.010721427806543253\ \(0\)\
\-\ advised\\:\\ 0\\.010656497464319509\ \(0\)\
\-\ maintain\\:\\ 0\\.01036039502081265\ \(0\)\
\-\ lesion\\:\\ 0\\.010339932035646265\ \(0\)\
\-\ plaque\\:\\ 0\\.010201894609577924\ \(0\)\
\-\ 61\\:\\ 0\\.009963027307026211\ \(0\)\
\-\ evaluation\\:\\ 0\\.009830648696343793\ \(0\)\
\-\ was\\:\\ 0\\.00978492596251175\ \(0\)\
\-\ changes\\:\\ 0\\.009699199905881428\ \(0\)\
\-\ moderately\\:\\ 0\\.009670678794538956\ \(0\)\
\-\ sweats\\:\\ 0\\.009632227139376377\ \(0\)\
\-\ weeks\\:\\ 0\\.009605060423370884\ \(0\)\
\-\ altered\\:\\ 0\\.009594507941414608\ \(0\)\
\-\ journal\\:\\ 0\\.009594507941414608\ \(0\)\
\-\ has\\:\\ 0\\.009532871111847196\ \(0\)\
\-\ childhood\\:\\ 0\\.009521158888582232\ \(0\)\
\-\ a\\:\\ 0\\.009424153706580625\ \(0\)\
\-\ neurofibroma\\:\\ 0\\.009382140554575799\ \(0\)\
\-\ various\\:\\ 0\\.009348859132167125\ \(0\)\
\-\ been\\:\\ 0\\.009207108473124717\ \(0\)\
\-\ axillary\\:\\ 0\\.009190358720932398\ \(0\)\
\-\ if\\:\\ 0\\.009183142312002516\ \(0\)\
\-\ dermatology\\:\\ 0\\.009130348127872341\ \(0\)\
\-\ source\\:\\ 0\\.00893357095200461\ \(0\)\
\-\ is\\:\\ 0\\.008907576687282783\ \(0\)\
\-\ developing\\:\\ 0\\.008854877231906562\ \(0\)\
\-\ who\\:\\ 0\\.008823637263927533\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.008804100141583122\ \(0\)\
\-\ delivery\\:\\ 0\\.008682577475491454\ \(0\)\
\-\ minor\\:\\ 0\\.008682577475491454\ \(0\)\
\-\ undergo\\:\\ 0\\.008590458632650082\ \(0\)\
\-\ began\\:\\ 0\\.008568083275711602\ \(0\)\
\-\ rapid\\:\\ 0\\.008545957927992542\ \(0\)\
\-\ invasive\\:\\ 0\\.00850243534043061\ \(0\)\
\-\ chills\\:\\ 0\\.008459848795438603\ \(0\)\
\-\ pmh\\:\\ 0\\.008418158876234975\ \(0\)\
\-\ increased\\:\\ 0\\.008279147650691706\ \(0\)\
\-\ night\\:\\ 0\\.008221939267038477\ \(0\)\
\-\ potential\\:\\ 0\\.008148590214206103\ \(0\)\
\-\ lead\\:\\ 0\\.008112910005289908\ \(0\)\
\-\ american\\:\\ 0\\.00806056692198663\ \(0\)\
\-\ fevers\\:\\ 0\\.008043422243287393\ \(0\)\
\-\ volume\\:\\ 0\\.00799286124921776\ \(0\)\
\-\ physician\\:\\ 0\\.007976290457790995\ \(0\)\
\-\ current\\:\\ 0\\.007927394195235802\ \(0\)\
\-\ problems\\:\\ 0\\.00783308122694025\ \(0\)\
\-\ regular\\:\\ 0\\.0078026160411194985\ \(0\)\
\-\ sensation\\:\\ 0\\.007772612466821277\ \(0\)\
\-\ 21\\:\\ 0\\.007656947591264019\ \(0\)\
\-\ present\\:\\ 0\\.007643599025472003\ \(0\)\
\-\ lower\\:\\ 0\\.007611334928173713\ \(0\)\
\-\ to\\:\\ 0\\.007611114803934408\ \(0\)\
\-\ left\\:\\ 0\\.007573111043745859\ \(0\)\
\-\ 22\\:\\ 0\\.0075476675604377015\ \(0\)\
\-\ difficult\\:\\ 0\\.0074066229875894484\ \(0\)\
\-\ 18\\:\\ 0\\.00734568901003152\ \(0\)\
\-\ below\\:\\ 0\\.00734568901003152\ \(0\)\
\-\ full\\:\\ 0\\.007310008801115325\ \(0\)\
\-\ on\\:\\ 0\\.007167237746192357\ \(0\)\
\-\ denies\\:\\ 0\\.007140657962623915\ \(0\)\
\-\ eye\\:\\ 0\\.007097841202201805\ \(0\)\
\-\ rule\\:\\ 0\\.007066325449120816\ \(0\)\
\-\ specific\\:\\ 0\\.006994682564808931\ \(0\)\
\-\ stable\\:\\ 0\\.006974680394538626\ \(0\)\
\-\ especially\\:\\ 0\\.006964754569145469\ \(0\)\
\-\ many\\:\\ 0\\.006954878249321629\ \(0\)\
\-\ at\\:\\ 0\\.006877800907910691\ \(0\)\
\-\ tender\\:\\ 0\\.006868140382671345\ \(0\)\
\-\ treatment\\:\\ 0\\.006849968156835196\ \(0\)\
\-\ slightly\\:\\ 0\\.006840051996548659\ \(0\)\
\-\ includes\\:\\ 0\\.006821545338294724\ \(0\)\
\-\ no\\:\\ 0\\.0068153992134954615\ \(0\)\
\-\ complications\\:\\ 0\\.006705292663390212\ \(0\)\
\-\ leg\\:\\ 0\\.006653856056651083\ \(0\)\
\-\ \\?\\:\\ 0\\.006603721783414865\ \(0\)\
\-\ change\\:\\ 0\\.006595488099952165\ \(0\)\
\-\ causes\\:\\ 0\\.006587288510514478\ \(0\)\
\-\ occur\\:\\ 0\\.0063486071857060174\ \(0\)\
\-\ which\\:\\ 0\\.006317404305911084\ \(0\)\
\-\ weakness\\:\\ 0\\.0062843789168878905\ \(0\)\
\-\ could\\:\\ 0\\.006242688997684262\ \(0\)\
\-\ since\\:\\ 0\\.00621537548851132\ \(0\)\
\-\ pain\\:\\ 0\\.006199652480380602\ \(0\)\
\-\ extremity\\:\\ 0\\.006188433603252352\ \(0\)\
\-\ very\\:\\ 0\\.006142149739519068\ \(0\)\
\-\ risk\\:\\ 0\\.006129122073978389\ \(0\)\
\-\ later\\:\\ 0\\.006109739883154304\ \(0\)\
\-\ weight\\:\\ 0\\.0060652391784967626\ \(0\)\
\-\ complete\\:\\ 0\\.005955199869279316\ \(0\)\
\-\ or\\:\\ 0\\.005949640092853708\ \(0\)\
\-\ the\\:\\ 0\\.00574898015599236\ \(0\)\
\-\ this\\:\\ 0\\.005709726019687919\ \(0\)\
\-\ 10\\:\\ 0\\.005704206392766159\ \(0\)\
\-\ palpation\\:\\ 0\\.005647404119501093\ \(0\)\
\-\ out\\:\\ 0\\.005592185894769339\ \(0\)\
\-\ back\\:\\ 0\\.0055823095749455\ \(0\)\
\-\ x\\:\\ 0\\.0055823095749455\ \(0\)\
\-\ showed\\:\\ 0\\.005548125283017221\ \(0\)\
\-\ revealed\\:\\ 0\\.005430641366071472\ \(0\)\
\-\ further\\:\\ 0\\.005381077508515362\ \(0\)\
\-\ differential\\:\\ 0\\.005372197681886989\ \(0\)\
\-\ any\\:\\ 0\\.005328386204103552\ \(0\)\
\-\ resection\\:\\ 0\\.0052770607040004336\ \(0\)\
\-\ be\\:\\ 0\\.005218838508292789\ \(0\)\
\-\ days\\:\\ 0\\.005186285734994015\ \(0\)\
\-\ during\\:\\ 0\\.005178236138462986\ \(0\)\
\-\ there\\:\\ 0\\.005036497253326688\ \(0\)\
\-\ primary\\:\\ 0\\.005012642104743953\ \(0\)\
\-\ in\\:\\ 0\\.005006699764042633\ \(0\)\
\-\ years\\:\\ 0\\.004968798291125708\ \(0\)\
\-\ loss\\:\\ 0\\.0049118102425117615\ \(0\)\
\-\ time\\:\\ 0\\.004779408370770916\ \(0\)\
\-\ performed\\:\\ 0\\.004717976893519444\ \(0\)\
\-\ trauma\\:\\ 0\\.004627740161896889\ \(0\)\
\-\ presented\\:\\ 0\\.004612589376281999\ \(0\)\
\-\ one\\:\\ 0\\.0045856066996250375\ \(0\)\
\-\ these\\:\\ 0\\.00440365285536206\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.004158683242835281\ \(0\)\
\-\ consistent\\:\\ 0\\.004149105482834065\ \(0\)\
\-\ bilateral\\:\\ 0\\.004106569761018701\ \(0\)\
\-\ upper\\:\\ 0\\.0040833277334034026\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.004078711885113352\ \(0\)\
\-\ into\\:\\ 0\\.0040263888474449646\ \(0\)\
\-\ noted\\:\\ 0\\.004010735026638799\ \(0\)\
\-\ without\\:\\ 0\\.003984184487837941\ \(0\)\
\-\ \\%\\:\\ 0\\.003947170363061401\ \(0\)\
\-\ tumor\\:\\ 0\\.00394501445863527\ \(0\)\
\-\ demonstrate\\:\\ 0\\.003893964636303051\ \(0\)\
\-\ it\\:\\ 0\\.0038036601673921123\ \(0\)\
\-\ year\\:\\ 0\\.0037865555218729295\ \(0\)\
\-\ \\'s\\:\\ 0\\.0037307853829050396\ \(0\)\
\-\ exam\\:\\ 0\\.003717294930593145\ \(0\)\
\-\ have\\:\\ 0\\.003664233818544736\ \(0\)\
\-\ and\\:\\ 0\\.003564534766974623\ \(0\)\
\-\ multiple\\:\\ 0\\.003563972284117364\ \(0\)\
\-\ after\\:\\ 0\\.0035009924804142623\ \(0\)\
\-\ old\\:\\ 0\\.0034650875123257607\ \(0\)\
\-\ presents\\:\\ 0\\.0034567213772434178\ \(0\)\
\-\ images\\:\\ 0\\.0032460671127709983\ \(0\)\
\-\ that\\:\\ 0\\.0029227341159580662\ \(0\)\
\-\ by\\:\\ 0\\.002817566145039356\ \(0\)\
\-\ of\\:\\ 0\\.0027684071476749726\ \(0\)\
\-\ as\\:\\ 0\\.0025595594176121344\ \(0\)\
\-\ from\\:\\ 0\\.0025077934913944797\ \(0\)\
\-\ an\\:\\ 0\\.002339930424326198\ \(0\)\
\-\ with\\:\\ 0\\.0018535315024140948\ \(0\)\
\-\ \\.\\:\\ 0\\.001827698888180204\ \(0\)\
\-\ \\(\\:\\ 0\\.0014304192598888327\ \(0\)\
\-\ \\)\\:\\ 0\\.0014129459249768417\ \(0\)\
